Eurofins BioPharma Services Newsletter 21 - October 2018
ARTICLES:
- Cost-effective, high-quality USP Reference Standards essential for compendial testing
- Eurofins CDMO: highly potent drug development from early stage
- Protein formulation studies to optimise biopharma products' shelf-life
- Eurofins Lancaster Labs offers several options for container-closure integrity testing
- Inhalation testing enhances Eurofins BPT service portfolio for all drug delivery systems
- Innovative, specialised testing from Viracor Eurofins helps biopharma companies and healthcare professionals improve patient care
Download the PDF version of pharma newsletter N°21
